These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2979064)

  • 81. Cellular aspects of folate and antifolate membrane transport.
    Brzezińska A; Wińska P; Balińska M
    Acta Biochim Pol; 2000; 47(3):735-49. PubMed ID: 11310973
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
    Volpato JP; Pelletier JN
    Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
    Jones RJ; Twelves CJ
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Riboflavin and cancer: a review.
    Rivlin RS
    Cancer Res; 1973 Sep; 33(9):1977-86. PubMed ID: 4579772
    [No Abstract]   [Full Text] [Related]  

  • 86. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.
    Villela LR; Stanford BL; Shah SR
    Pharmacotherapy; 2006 May; 26(5):641-54. PubMed ID: 16637794
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 90. Immunotoxins.
    Pastan I; Willingham MC; FitzGerald DJ
    Cell; 1986 Dec; 47(5):641-8. PubMed ID: 3536124
    [No Abstract]   [Full Text] [Related]  

  • 91. Immunotoxins: an overview.
    Uhr JW
    Semin Cell Biol; 1991 Feb; 2(1):1-6. PubMed ID: 1954338
    [No Abstract]   [Full Text] [Related]  

  • 92. Targeting of liposomes to tumor cells in vivo.
    Papahadjopoulos D; Gabizon A
    Ann N Y Acad Sci; 1987; 507():64-74. PubMed ID: 3327419
    [No Abstract]   [Full Text] [Related]  

  • 93. Folate antagonists.
    Bertino JR; Johns DG
    Annu Rev Med; 1967; 18():27-34. PubMed ID: 5337527
    [No Abstract]   [Full Text] [Related]  

  • 94. Immunotoxins: status and prospects.
    Spooner RA; Lord JM
    Trends Biotechnol; 1990 Jul; 8(7):189-93. PubMed ID: 1366624
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeting enzyme albumin conjugates. Examining the magic bullet.
    Poznansky MJ
    Ann N Y Acad Sci; 1987; 507():211-9. PubMed ID: 3327414
    [No Abstract]   [Full Text] [Related]  

  • 96. Synthesis and testing of antibody-antifolate conjugates for drug targeting.
    Ghose T; Blair AH; Kralovec J; Mammen M; Uadia PO
    Targeted Diagn Ther; 1988; 1():81-122. PubMed ID: 2979064
    [No Abstract]   [Full Text] [Related]  

  • 97. Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
    Smyth MJ; Pietersz GA; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():123-56. PubMed ID: 2979055
    [No Abstract]   [Full Text] [Related]  

  • 98. KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies.
    Bumol TF; Baker AL; Andrews EL; DeHerdt SV; Briggs SL; Spearman ME; Apelgren LD
    Targeted Diagn Ther; 1988; 1():55-79. PubMed ID: 2979063
    [No Abstract]   [Full Text] [Related]  

  • 99. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.